The levels of anti-SARS-CoV-2 spike protein IgG antibodies before and after the third dose of vaccination against COVID-19
M Łysek-Gładysińska, M Starz… - Journal of …, 2023 - Taylor & Francis
Purpose The COVID-19 pandemic has been going on for almost three years, and so far,
many preventive and therapeutic strategies have been developed. The issue of subsequent …
many preventive and therapeutic strategies have been developed. The issue of subsequent …
Use of oral antivirals ritonavir-nirmatrelvir and molnupiravir in patients with multiple myeloma is associated with low rates of severe COVID-19: a single-center …
V Spiliopoulou, I Ntanasis-Stathopoulos, P Malandrakis… - Viruses, 2023 - mdpi.com
In patients with multiple myeloma (MM), SARS-CoV-2 infection has been associated with a
severe clinical course and high mortality rates due to the concomitant disease-and treatment …
severe clinical course and high mortality rates due to the concomitant disease-and treatment …
Immune response to SARS-CoV-2 mRNA vaccines in an open-label multicenter study in participants with relapsing multiple sclerosis treated with ofatumumab
T Ziemssen, M Groth, B Ettle, T Bopp - Vaccines, 2022 - mdpi.com
Background: It is unclear whether multiple sclerosis (MS) patients receiving ofatumumab
mount an immune response after SARS-CoV-2 mRNA vaccination. Methods: KYRIOS is an …
mount an immune response after SARS-CoV-2 mRNA vaccination. Methods: KYRIOS is an …
Antibody-dependent enhancement with a focus on SARS-coV-2 and anti-glycan antibodies
MM Ziganshina, NV Shilova, EO Khalturina… - Viruses, 2023 - mdpi.com
Antibody-dependent enhancement (ADE) is a phenomenon where virus-specific antibodies
paradoxically cause enhanced viral replication and/or excessive immune responses …
paradoxically cause enhanced viral replication and/or excessive immune responses …
A severe acute respiratory syndrome coronavirus 2 anti-spike immunoglobulin G assay: a robust method for evaluation of vaccine immunogenicity using an …
M Zhu, S Cloney-Clark, S Feng, A Parekh, D Gorinson… - Microorganisms, 2023 - mdpi.com
As the COVID-19 pandemic continues, variants of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) continue to emerge. Immunogenicity evaluation of vaccines …
coronavirus 2 (SARS-CoV-2) continue to emerge. Immunogenicity evaluation of vaccines …
A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA
Background Cancer patients have an increased risk of a severe COVID-19 infection with
higher mortality rate. This study aimed to analyze the levels of anti-SARS-CoV-2 S-RBD IgG …
higher mortality rate. This study aimed to analyze the levels of anti-SARS-CoV-2 S-RBD IgG …
Assessment of the biological impact of SARS-CoV-2 genetic variation using an authentic virus neutralisation assay with convalescent plasma, vaccinee sera, and …
NS Coombes, KR Bewley, Y Le Duff, M Hurley… - Viruses, 2023 - mdpi.com
In the summer of 2020, it became clear that the genetic composition of SARS-CoV-2 was
changing rapidly. This was highlighted by the rapid emergence of the D614G mutation at …
changing rapidly. This was highlighted by the rapid emergence of the D614G mutation at …
Factors associated with the decay of anti-SARS-CoV-2 S1 IgG antibodies among recipients of an adenoviral vector-based AZD1222 and a whole-virion inactivated …
ST Selvavinayagam, YK Yong, HY Tan, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
Background The magnitude of protection conferred following recovery from COVID-19 or by
vaccine administration, and the duration of protective immunity developed, remains …
vaccine administration, and the duration of protective immunity developed, remains …
Correlation of binding and neutralizing antibodies against SARS-CoV-2 omicron variant in infection-naïve and convalescent BNT162b2 recipients
J Fu, X Shen, M Anderson, M Stec, T Petratos… - Vaccines, 2022 - mdpi.com
In vaccine clinical trials, both binding antibody (bAb) levels and neutralization antibody
(nAb) titers have been shown to be correlates of SARS-CoV-2 vaccine efficacy. We report a …
(nAb) titers have been shown to be correlates of SARS-CoV-2 vaccine efficacy. We report a …
Immunoglobulin A response to SARS-CoV-2 infection and immunity
The novel coronavirus disease (COVID-19) and its infamous" Variants" of the etiological
agent termed Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) has …
agent termed Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) has …